Awshad, a medical cannabis wellness startup, has turned profitable in FY25 and marked the milestone with the launch of its most potent product to date a 6500mg CBD oil. The launch coincides with Awshad’s fourth anniversary, making it one of the first homegrown players in India’s medical cannabis wellness industry to achieve profitability.
The 6500mg CBD Oil is the most powerful and potent CBD oil ever introduced by Awshad. The high strength of the oil promises to give relief from chronic pain, cancer, epilepsy, severe anxiety, and insomnia. At 6500mg, it is Awshad’s strongest formulation to date and reflects the company’s commitment to pushing the limits of cannabis-based wellness medicine in India.
Mr. Shivam Singhee, CEO & Co-founder of Awshad, said: “When we founded Awshad back in 2021, the concept of medical cannabis was very foreign in India. But we really believed that CBD oil can revolutionise and redefine the wellness industry in India. I am proud to share that 2025 marks our first profitable year, which validates not only our product-market fit but also the trust we have built in the market. Our newly launched 6500mg CBD Oil is our most potent formula to date, and we are confident that it will be a game-changer for the wellness industry in India. We look forward to stepping into our next phase of growth as we introduce more innovative and category-defining products in the coming years.”
Ms Richa Jaggi, Co-founder & CMO, Awshad added: “Awshad has come a long way from being a small startup built with a deep purpose to being one of the market leaders in the CBD wellness industry. Profitability not only validates our business model but also gives us more credibility among future investors and our customers. We know we are on the right track when more than 10,000 customers have trusted us for their health and well-being. The next frontier for us is to scale the company and collaborate with changemakers, including doctors, researchers, and regulators, to make CBD-based wellness products mainstream in society.”
Awshad has grown from a niche startup to an established wellness player in the market, expanding their product offerings from CBD oils to capsules, mushroom supplements, gummies and pet products. And with the newly launched 6500mg CBD oil, it further aims to strengthen its position in the wellness landscape in India. The company has more than 10,000 customers till date and has grown 20x since its inception. The major market for Awshad includes all metro cities of India, with smaller towns like Jaipur, Indore emerging as new markets. Millennials make up the biggest share of Awshad’s CBD-based product users.
The success of Awshad proves the growing demand for cannabis based medical and wellness products in India. The India Cannabis Based Product market size is projected to grow at a CAGR of 17.34% and is estimated to grow from USD 1.3 billion in FY24 to USD 4.7 billion in FY32. A host of factors, including ending the stigma around Cannabis products, awareness campaigns by brands with supportive governmental policies and better regulations, are being a catalyst to this growth story. According to experts, the education, marketing strategy and innovation of Awshad have given them a competitive advantage, which has helped them to succeed in an industry often surrounded by stigma and myths.
Awshad plans to foray into newer categories in the coming years through innovative products and expanded product offerings. Their vision is to make CBD-based wellness offerings more accessible, affordable and acceptable to the masses and to cement their position as the most trusted CBD-based wellness brand in India. The right policies from the government and awareness campaigns from doctors and various other stakeholders can transform the CBD-based wellness industry in the coming decade.
